Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
And has never been canceled. Just saying.
Yes, it does matter. Claiming that certain filings are in when they are not is straight-up lying.
Phase II would be July, minimum, and that's if funding is found.
That's a 10-Q, not a 10-K.
Seeing as the company themselves have now said trials are not planned to commence until the third quarter, assuming funding is found, I would say that the "trialstracker" 3rd party website is absolutely full of crap when it says that the trial is currently ongoing.
Third quarter starts in July.
It seems the trials have not started yet. I guess we'll revisit that March promise again in a couple days, won't we? I'm guessing it won't have started, seeing as how we haven't even gotten any word about the manufacturing facility they need to set up first.
"Fully funded" is nowhere in the POR no matter how many times that claim is made. Just like the claim of "no reverse split" that was made over and over and over. It's just not in there when you actually read it. Yes, some of us do actually read and understand when we are being presented with opinions that do not agree with reality.
How are the trials coming along?
Did they start March 2 like had been promised over and over and over and over?
Can we finally see some details about how they have been fully funded for some time now as had been promised over and over and over?
I really hope all those promises over the last months weren't just a bunch of hot air.
Interestingly enough, Paulson is the Market Maker PAUL that has been causing such consternation in the BRTX Level 2. Small world, huh?
They are a known dilutor, among other reputations.
https://www.newyorksecuritieslawyersblog.com/the-wolves-are-still-on-wall-street-what-is-going-on-at-paulson-investment-company-llc/
I was simply correcting the mistaken opinion that there has been no dilution in a long time.
Shares were added to the OS as recently as a week ago.
That's dilution.
Oof, today's pump out of steam already? It's not even an hour in.
Claims that the market cap has suddenly magically increased are the crappiest of crap twitter pumping.
Seriously? It's the OS multiplied by the share price. That's market cap. It doesn't spontaneously increase multifold overnight.
Anyone on Twitter saying that it did is lying through their teeth.
Those compensation figures are directly from the audited 10-K. Why are they not accurate?
Getting sued for telling the truth, sounds legit.
The previous CEO and staffing were paid high salaries, (see past reports). Current management pays their key employees with shares or stock warrants. BRTX is still a penny stock company. They are utilizing this maneuver because they are not wanting to commit their cash for compensation. The team is instead paid with shares that have potential to increase in value the sale of which will be taxed at a lower rate than ordinary income.
On March 18, 2021, the Company and Lance Alstodt, its President, Chief Executive Officer and Chairman of the Board, entered into an employment agreement (the “Alstodt Employment Agreement”) which provides for a term ending on March 18, 2026. Pursuant to the Alstodt Employment Agreement, Mr. Alstodt is entitled to receive initially an annual salary of $250,000. Mr. Alstodt’s annual salary will increase by $50,000 per year. In addition, in the event certain performance goals are met, Mr. Alstodt’s salary will increase by $150,000. The Alstodt Employment Agreement also provides for the grant to Mr. Alstodt pursuant to the Plan of (i) a ten year option for the purchase of 1,173,917,974 shares of common stock of the Company and (ii) 586,958,987 restricted stock units of the Company (“RSUs”).
On March 18, 2021, the Company and Francisco Silva, its Vice President, Research and Development, entered into an employment agreement (the “Silva Employment Agreement”) which provides for a term ending on March 18, 2026. Pursuant to the Silva Employment Agreement, Mr. Silva is entitled to receive initially an annual salary of $225,000. Mr. Silva’s annual salary will increase by $50,000 per year. In addition, in the event certain performance goals are met, Mr. Silva’s salary will increase by $150,000. The Silva Employment Agreement also provides for the grant to Mr. Silva pursuant to the Plan of (i) a ten year option for the purchase of 1,173,917,974 shares of common stock of the Company and (ii) 586,958,987 RSUs.
Tall tales about trials being under way could be a quick path to getting the ticker suspended for promotion under false pretenses.
Something to keep in mind.
The only reason a lame third party site thinks the trial is ongoing is because it is past the date it was supposed to have started.
Go ahead, click the link that takes you to the legit .gov website. I dare you.
https://clinicaltrials.gov/ct2/show/NCT04042844
Yup, still not even recruiting yet.
Only idiots fall for that 3rd party stuff.
For share structure updates, always go straight to the source, OTC Markets.
The share structure has been posted here with the incorrect labeling of "no change" when there was in fact a change.
Straight-up malarky.
I've read them. Calling dilution "agency" does not change that it is still dilution.
So they added $17k worth of BRTX to their $700 million portfolio sometime last year, yah, it's not exactly "news".
It's not fresh and it's like less than .003% of their holdings.
Yet it's the most exciting BRTX development in some time, how sad is that?
Where do you see this? I like to confirm things for myself.
As has been mentioned, both the 7 and 10 million trades are signs of dilution. The 7 million is easy to recognize - it registered after hours. The 10 million during the day can be harder to identify as to dilution or an honest trade. One thing you can look at though is the share price that the transaction was reported at relative to the bid and ask at that moment in time. If they are not in line with each other then you know it was an average for a block that was reported instead of a single trade at that time.
The 10 million trade did not jive with the bid/ask. That's how you know it was dilution and not a "whale loading!"
That is an "estimated range" that appears to be just an option checked by some clerk somewhere.
The actual filing that actually details the assets and their values totals them at under one million dollars, in sum.
They are a year behind for their 2019 Annual Report.
Unfortunately, they are well beyond any period where the question "how much longer do they have?" would have made sense.
Regarding funding, if anyone tells you that the trials are already funded, tell them to prove it. They won't be able to. Because it is not.
Plus another 4.2 million in after hour t-trades, lovely.
PAUL is on the Ask. You're welcome.
The vast majority of which were aimed at suckering in the uneducated with promises such as fully funded trials beginning, oh, wait, 2 days ago? Oops. How's that coming along? Everything going according to plan there?
That was a t-trade, a sign of dilution. Not something one should be happy to see.
"It would be nice if CEO's executed according to their plan, but it's not mandatory."
Thank you for your opinion. When it comes to investing money, I am a little bit more critical. That's not a good precedent at all.
That was after a reverse split that was ostensibly done in preparation for NASDAQ uplisting, they PR'ed it and everything.
In classic OTC fashion, they sure did the split all right. But the supposed uplist? Nope, never happened.
One can try all they want to downplay it, but Lance has failed at the very first objective he laid out after emerging from bankruptcy.
We expect to file our 2019 10-K in February 2021
Frankly, I'm blown away that they flubbed it. I mean, they've had 3 months since emerging from the BK to put it together.
An extension deadline came and went a year ago. He's got until 5:30 if it is to count as a February filing.
No, they can't.
https://www.investopedia.com/terms/n/nbbo.asp
The National Best Bid and Offer (NBBO) is a Securities Exchange Commission (SEC) regulation requiring brokers to trade at the best available (lowest) ask price and the best available (highest) bid price when buying and selling securities for customers. The National Best Bid and Offer is the bid or ask price that the average customer will see. The Securities and Exchange Commission’s Regulation NMS requires that brokers guarantee their customers this price.
Isle Utilities is the wrong tree to bark up. That Andrea is just a junior consultant at the company, I really doubt he was suddenly promoted to President.
Direct listing means that they are not going the reverse merger route with any shell much less JADA.
"Fully funded trials" is nowhere to be found.
Nice try.
Here's the POR for anyone to read for themselves. You'll notice that it never mentions trials being fully funded as has been claimed.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=160026681
I've read the POR, that ain't in there.